The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1386
Nitroglycerin Ointment (Rectiv) for Anal Fissure
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

The FDA has approved the use of nitroglycerin ointment 0.4% (Rectiv – ProStrakan/Aptalis) for treatment of moderate to severe pain associated with chronic anal fissure; the same drug is marketed as Rectogesic in Europe. Nitroglycerin ointment 2% (Nitro-Bid) is available in the US for prevention of angina.

MECHANISM OF ACTION — Nitroglycerin is a vasodilator that relaxes smooth muscle. Applied topically, it causes relaxation of the anal sphincter.1

STANDARD TREATMENT — The most effective treatment for chronic anal fissure is a lateral internal anal sphincterotomy, which can be done under local anesthesia and results in a cure in about 95% of patients, but can cause varying degrees of fecal incontinence; a recent review found that this complication, which may persist, occurred in 9% of patients. ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Nitroglycerin Ointment (Rectiv) for Anal Fissure
Article code: 1386c
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian